BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹15 Cr | ₹31 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of BAL PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹12 Cr |
How is Net Current Assets of BAL PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -50.58 | |
| Mar2024 | ₹31 Cr | 65.25 | |
| Mar2023 | ₹19 Cr | -0.55 | |
| Mar2022 | ₹19 Cr | 62.96 | |
| Mar2021 | ₹12 Cr | - | |
Compare Net Current Assets of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹117.7 Cr | 1.8% | -1.3% | -38.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1.8% |
-1.3% |
-38.6% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses